S&W Seed Company (SANW) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Jan, 2026Executive summary
Fiscal 2024 revenue was $60.4 million, down from $73.5 million last year, mainly due to international declines and lower non-dormant alfalfa and non-traited sorghum sales, partially offset by strong Double Team sorghum growth.
Double Team sorghum revenue rose 68.1% to $10.9 million, driving gross margin improvement and expected to reach 10% of U.S. sorghum acres in 2024.
Company-wide gross margins improved to 26.2%, exceeding outlook, due to high-margin product mix and operational efficiencies.
S&W Australia entered Voluntary Administration in July 2024 due to financial challenges, impacting international operations.
International and Australian operations faced significant challenges, with international sales down sharply.
Financial highlights
Gross profit margin rose to 26.2% from 19.8% in 2023, with gross profit dollars up $1.3 million year-over-year.
Adjusted EBITDA improved to negative $8.5 million from negative $9.3 million last year.
GAAP net loss was $30.1 million, compared to net income of $14.49 million last year, which included a $38.2 million gain from a prior asset sale.
Adjusted net loss was $21.3 million, or $9.35 per share, versus $20.3 million, or $9.02 per share, in the prior year.
Cash and cash equivalents at year-end were $0.3 million, down from $3.4 million a year earlier.
Outlook and guidance
Double Team sorghum is expected to reach 13%-15% share of U.S. sorghum acres in 2025, up from 10% in 2024.
Full launch of Prussic Free trait in 2025, following a successful pilot.
Detailed fiscal 2025 outlook to be provided after the conclusion of the Australian VA process in November.
Focus remains on expanding Double Team operations in the Americas and resolving the VA process for international operations.
Latest events from S&W Seed Company
- Q1 revenue fell 22.8% to $8.3M; focus shifts to high-margin U.S. sorghum traits and break-even target.SANW
Q1 202513 Jan 2026 - Revenue and margins fell sharply amid restructuring, with a strategic review underway.SANW
Q2 202524 Dec 2025 - Vote on a reverse stock split to maintain Nasdaq compliance, with Board discretion on ratio and timing.SANW
Proxy Filing1 Dec 2025 - Board recommends approval of all annual meeting proposals, including expanded equity incentives.SANW
Proxy Filing1 Dec 2025 - Stockholders will vote on a reverse stock split to maintain Nasdaq listing and enhance liquidity.SANW
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay at the 2024 annual meeting.SANW
Proxy Filing1 Dec 2025 - Gross margin hit 37.7% and Adjusted EBITDA turned positive, but tariffs and liquidity risks remain.SANW
Q3 202527 Nov 2025